Annovis Bio Secures US Patent for Buntanetap Crystalline Form Through 2044
Annovis Bio strengthens its intellectual property portfolio with a US patent covering buntanetap Form B, ahead of anticipated Phase III Alzheimer's trial results in 2027.
Semi-crystalline Anhydrate | 16/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy